CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key market segments

1.2.1.List of key players profiled in the report

1.3.Research methodology

1.3.1.Primary research
1.3.2.Secondary research
1.3.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Top player positioning

3.2.1.Top investment pockets

3.3.Key forces shaping veterinary medicines industry/market
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in ownership of companion animals
3.4.1.2.Rise in livestock population across the globe
3.4.1.3.Rise in animal healthcare expenditure
3.4.1.4.Surge in prevalence of various medical conditions in animals

3.4.2.Restraint

3.4.2.1.Stringent regulatory approvals related to veterinary drugs and vaccines
3.4.2.2.Lack of veterinary infrastructure facilities in underdeveloped nations

3.4.3.Opportunity

3.4.3.1.Surge in awareness related to animal healthcare

3.4.4.Impact Analyses

3.5.Covid-19 impact analysis on global veterinary medicine market

CHAPTER 4:VETERINARY MEDICINE MARKET, BY PRODUCT

4.1.Overview

4.1.1.Market size and forecast

4.2.Drugs

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by type

4.2.2.1.Anti-infective

4.2.2.1.1.Market size and forecast

4.2.2.2.Anti-inflammatory

4.2.2.2.1.Market size and forecast

4.2.2.3.Parasiticide

4.2.2.3.1.Market size and forecast

4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country

4.3.Vaccines

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by type

4.3.2.1.Inactivated Vaccines

4.3.2.1.1.Market size and forecast

4.3.2.2.Attenuated Vaccines

4.3.2.2.1.Market size and forecast

4.3.2.3.Recombinant Vaccines

4.3.2.3.1.Market size and forecast

4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country

4.4.Medicated feed additives

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by type

4.4.2.1.Amino Acids

4.4.2.1.1.Market size and forecast

4.4.2.2.Antibiotics

4.4.2.2.1.Market size and forecast

4.4.3.Market size and forecast, by region
4.4.4.Market analysis, by country

CHAPTER 5:VETERINARY MEDICINE MARKET, BY ROUTE OF ADMINSTRATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Oral route

5.2.1.Market size and forecast, by region
5.2.2.Market analysis by country

5.3.Parenteral route

5.3.1.Market size and forecast, by region
5.3.2.Market analysis by country

5.4.Topical route

5.4.1.Market size and forecast, by region
5.4.2.Market analysis by country

CHAPTER 6:VETERINARY MEDICINE MARKET, BY ANIMAL TYPE

6.1.Overview

6.1.1.Market size and forecast

6.2.Companion animal

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Livestock animals

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

CHAPTER 7:VETERINARY MEDICINE MARKET, BY DISTRIBUTION CHANNEL

7.1.Overview

7.1.1.Market size and forecast

7.2.Veterinary hospital pharmacies

7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country

7.3.Retail veterinary pharmacies

7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country

CHAPTER 8:VETERINARY MEDICINE MARKET, BY REGION

8.1.Overview

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.Market analysis, by country

8.2.2.1.U.S.

8.2.2.1.1.U.S. market size and forecast, by product
8.2.2.1.2.U.S. market size and forecast, by route of administration
8.2.2.1.3.U.S. market size and forecast, by animal type
8.2.2.1.4.U.S. market size and forecast, by distribution channel

8.2.2.2.Canada

8.2.2.2.1.Canada market size and forecast, by product
8.2.2.2.2.Canada market size and forecast, by route of administration
8.2.2.2.3.Canada market size and forecast, by animal type
8.2.2.2.4.Canada market size and forecast, by distribution channel

8.2.2.3.Mexico

8.2.2.3.1.Mexico market size and forecast, by product
8.2.2.3.2.Mexico market size and forecast, by route of administration
8.2.2.3.3.Mexico market size and forecast, by animal type
8.2.2.3.4.Mexico market size and forecast, by distribution channel

8.2.3.North America market size and forecast, by product
8.2.4.North America market size and forecast, by route of administration
8.2.5.North America market size and forecast, by animal type
8.2.6.North America market size and forecast, by distribution channel

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Market analysis, by country

8.3.2.1.Germany

8.3.2.1.1.Germany market size and forecast, by product
8.3.2.1.2.Germany market size and forecast, by route of administration
8.3.2.1.3.Germany market size and forecast, by animal type
8.3.2.1.4.Germany market size and forecast, by distribution channel

8.3.2.2.France

8.3.2.2.1.France market size and forecast, by product
8.3.2.2.2.France market size and forecast, by route of administration
8.3.2.2.3.France market size and forecast, by animal type
8.3.2.2.4.France market size and forecast, by distribution channel

8.3.2.3.UK

8.3.2.3.1.UK market size and forecast, by product
8.3.2.3.2.UK market size and forecast, by route of administration
8.3.2.3.3.UK market size and forecast, by animal type
8.3.2.3.4.UK market size and forecast, by distribution channel

8.3.2.4.Italy

8.3.2.4.1.Italy market size and forecast, by product
8.3.2.4.2.Italy market size and forecast, by route of administration
8.3.2.4.3.Italy market size and forecast, by animal type
8.3.2.4.4.Italy market size and forecast, by distribution channel

8.3.2.5.Spain

8.3.2.5.1.Spain market size and forecast, by product
8.3.2.5.2.Spain market size and forecast, by route of administration
8.3.2.5.3.Spain market size and forecast, by animal type
8.3.2.5.4.Spain market size and forecast, by distribution channel

8.3.2.6.Rest of Europe

8.3.2.6.1.Rest of Europe market size and forecast, by product
8.3.2.6.2.Rest of Europe market size and forecast, by route of administration
8.3.2.6.3.Rest of Europe market size and forecast, by animal type
8.3.2.6.4.Rest of Europe market size and forecast, by distribution channel

8.3.3.Europe market size and forecast, by product
8.3.4.Europe market size and forecast, by route of administration
8.3.5.Europe market size and forecast, by animal type
8.3.6.Europe market size and forecast, by distribution channel

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Market analysis, by country

8.4.2.1.Japan

8.4.2.1.1.Japan market size and forecast, by product
8.4.2.1.2.Japan market size and forecast, by route of administration
8.4.2.1.3.Japan market size and forecast, by animal type
8.4.2.1.4.Japan market size and forecast, by distribution channel

8.4.2.2.China

8.4.2.2.1.China market size and forecast, by product
8.4.2.2.2.China market size and forecast, by route of administration
8.4.2.2.3.China market size and forecast, by animal type
8.4.2.2.4.China market size and forecast, by distribution channel

8.4.2.3.Australia

8.4.2.3.1.Australia market size and forecast, by product
8.4.2.3.2.Australia market size and forecast, by route of administration
8.4.2.3.3.Australia market size and forecast, by animal type
8.4.2.3.4.Australia market size and forecast, by distribution channel

8.4.2.4.India

8.4.2.4.1.India market size and forecast, by product
8.4.2.4.2.India market size and forecast, by route of administration
8.4.2.4.3.India market size and forecast, by animal type
8.4.2.4.4.India market size and forecast, by distribution channel

8.4.2.5.South Korea

8.4.2.5.1.South Korea market size and forecast, by product
8.4.2.5.2.South Korea market size and forecast, by route of administration
8.4.2.5.3.South Korea market size and forecast, by animal type
8.4.2.5.4.South Korea market size and forecast, by distribution channel

8.4.2.6.Rest of Asia-Pacific

8.4.2.6.1.Rest of Asia-Pacific market size and forecast, by product
8.4.2.6.2.Rest of Asia-Pacific market size and forecast, by route of administration
8.4.2.6.3.Rest of Asia-Pacific market size and forecast, by animal type
8.4.2.6.4.Rest of Asia-Pacific market size and forecast, by distribution channel

8.4.3.Asia-Pacific market size and forecast, by product
8.4.4.Asia-Pacific market size and forecast, by route of administration
8.4.5.Asia-Pacific market size and forecast, by animal type
8.4.6.Asia-Pacific market size and forecast, by distribution channel

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.Market analysis, by country

8.5.2.1.Brazil

8.5.2.1.1.Brazil market size and forecast, by product
8.5.2.1.2.Brazil market size and forecast, by route of administration
8.5.2.1.3.Brazil market size and forecast, by animal type
8.5.2.1.4.Brazil market size and forecast, by distribution channel

8.5.2.2.Saudi Arabia

8.5.2.2.1.Saudi Arabia market size and forecast, by product
8.5.2.2.2.Saudi Arabia market size and forecast, by route of administration
8.5.2.2.3.Saudi Arabia market size and forecast, by animal type
8.5.2.2.4.Saudi Arabia market size and forecast, by distribution channel

8.5.2.3.South Africa

8.5.2.3.1.South Africa market size and forecast, by product
8.5.2.3.2.South Africa market size and forecast, by route of administration
8.5.2.3.3.South Africa market size and forecast, by animal type
8.5.2.3.4.South Africa market size and forecast, by distribution channel

8.5.2.4.Rest of LAMEA

8.5.2.4.1.Rest of LAMEA market size and forecast, by product
8.5.2.4.2.Rest of LAMEA market size and forecast, by route of administration
8.5.2.4.3.Rest of LAMEA market size and forecast, by animal type
8.5.2.4.4.Rest of LAMEA market size and forecast, by distribution channel

8.5.3.LAMEA market size and forecast, by product
8.5.4.LAMEA market size and forecast, by route of administration
8.5.5.LAMEA market size and forecast, by animal type
8.5.6.LAMEA market size and forecast, by distribution channel

CHAPTER 9:COMPANY PROFILES

9.1.Archer Daniels Midland

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance

9.2.Boehringer Ingelheim International GmbH

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance

9.3.Ceva Sant Animale

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio

9.4.Dechra Pharmaceuticals PLC.

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance

9.5.Elanco Animal Health Incorporated.

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance.
9.5.6.Key strategic moves and developments

9.6.Evonik Industries AG (RAG Stiftung)

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.Merck & Co., Inc.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.Soparfin SCA.

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Key strategic moves and developments

9.9.Virbac SA.

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments

9.10.Zoetis Inc.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments